Research And Markets Research And Markets

DrugPatentWatch Ultimate Plan

  • ID: 1303222
  • May 2015
  • thinkBiotech LLC
1 of 3

DrugPatentWatch provides information on drug patents and their expirations. Datasets include Paragraph IV challenges, tentative approval (an indicator of generic entry), patent claim types, annual sales, patent expirations, failure to pay maintenance fees, ex parte and inter partes reexamination, interference, and disclaimers. Complete details are provided for all FDA-approved small molecule drugs. Annual sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.

The Ultimate Plan provides comprehensive information on all FDA-approved pharmaceutical drugs - discontinued and active, with and without patent protection or other forms of market exclusivity.

Information on failure to pay patent maintenance fees, ex parte and inter partes reexaminations, interferences, and disclaimers, can help predict when patents will be delisted, months in advance.

Paragraph IV listings indicate which drugs are facing patent challenges, and can help predict early generic entry.

A historical archive, exclusively offered by DrugPatentWatch, helps you identify the expired patents that once covered specific pharmaceutical READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Database includes:

Export search results

Sales data (top 200-selling drugs)

Impending patent expirations
Patent expiration date
Patent title and abstract
Pediatric exclusivity extensions
Patent interferences
Patent disclaimers
Patent reexaminations
Paragraph IV challenges
Download full-text patent PDF
Patent claim types (use, compound, formulation, etc.)

Search by applicant name
Search by approval date
Search by branded name
Search by generic name
Search by NDA Number
Search by patent number
Search by therapeutic class
Search by dosage type

Regulatory exclusivity
Use codes
Tenative approvals (an indicator of generic entrants)

Dynamic graphs
Historical archives

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown